Access Bio Solutions: Rapid Infectious Disease Testing

Rapid infectious disease testing is essential for managing public health, enabling timely diagnosis and response to outbreaks. Access Bio Solutions provides innovative diagnostic tools to meet this urgent need.

Rapid SARS-CoV-2 Test Offerings

Access Bio Solutions has been pivotal in developing rapid SARS-CoV-2 tests, crucial for managing the COVID-19 pandemic. These tests deliver quick and reliable results, essential for healthcare providers and individuals. The company offers rapid antigen tests validated through rigorous clinical trials, with a sensitivity of approximately 84% and a specificity of 99%, according to The Lancet. These tests use lateral flow technology to detect viral proteins, providing results within 15 to 30 minutes. Their ease of use makes them ideal for settings needing immediate results, such as airports and schools. The World Health Organization emphasizes rapid testing’s role in controlling COVID-19 spread.

In addition to antigen tests, Access Bio Solutions has developed rapid molecular tests using loop-mediated isothermal amplification (LAMP) to detect viral RNA. These tests offer enhanced sensitivity and faster processing times, making them suitable for settings with limited laboratory infrastructure. The U.S. Food and Drug Administration has granted Emergency Use Authorization for several of Access Bio’s SARS-CoV-2 tests, underscoring their compliance with safety and efficacy standards.

Lateral Flow Immunoassays

Lateral flow immunoassays (LFAs) are transformative in rapid diagnostic testing, providing a versatile platform for detecting various pathogens. These assays use immunochromatography, where a sample moves along a test strip with antibodies specific to the target antigen. This mechanism is effective for both clinical and non-clinical settings due to its adaptability and rapid turnaround time. LFAs are portable and require minimal training, making them suitable for remote or resource-limited environments. Innovations in antibody production and detection methodologies have improved LFAs’ specificity and sensitivity, achieving performance comparable to complex laboratory techniques.

Infectious Disease Diagnoses

Access Bio Solutions addresses various infectious diseases beyond SARS-CoV-2, developing targeted tests for specific pathogens.

Malaria

Malaria is a significant health concern in tropical regions. Access Bio Solutions offers rapid diagnostic tests (RDTs) that detect Plasmodium antigens in human blood. These tests are designed to identify Plasmodium falciparum, the most deadly malaria parasite, and other species. According to The American Journal of Tropical Medicine and Hygiene, these RDTs demonstrate high sensitivity and specificity, facilitating early detection and treatment in remote areas.

HIV

Access Bio Solutions provides HIV rapid tests that detect antibodies to the virus, delivering results in as little as 20 minutes. These tests are crucial for screening and monitoring, particularly in regions with high HIV prevalence. A meta-analysis in the Journal of Acquired Immune Deficiency Syndromes highlights the effectiveness of rapid HIV tests in increasing testing uptake and linkage to care.

Other Pathogens

Access Bio Solutions has expanded its diagnostic portfolio to include tests for hepatitis B and C, dengue, and syphilis. These tests offer rapid and reliable results, aiding in timely clinical decision-making. For instance, rapid detection of dengue virus antigens can help manage outbreaks effectively, as noted in PLOS Neglected Tropical Diseases.

International Distribution Networks

Access Bio Solutions has developed an extensive international distribution network to ensure their rapid diagnostic tests reach global markets efficiently. By partnering with distributors, Access Bio ensures its products are available in regions with varying healthcare systems. These collaborations facilitate the integration of tests into existing public health frameworks, particularly in areas with underdeveloped healthcare infrastructure.